Stock Market

Humana third-quarter earnings and revenue top estimates

Investing | Thu, Oct 31 2024 02:07 AM AEDT

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz

Investing.com -- Humana (NYSE:HUM) has reported third-quarter profit and revenue that topped estimates, in a positive development for the health insurance group following recent setbacks.

Earlier this month, the stock fell after the US government released the results of its quality ratings for 2025 Medicare health and prescription drug plans.

The numbers showed that 25% of Humana's members had signed up for plans that had ratings of 4 stars or above in 2025 -- down from 94% in the prior year. Much of this decrease was due to the rating of Humana's H5216 contract being lowered to 3.5 stars from 4.5 stars, the company has said.

Humana has flagged the decline will impact its quality bonus payments in 2026. The Centers for Medicare and Medicaid typically awards a quality bonus to health plans that achieve 4 stars or higher.

Analysts have suggested that litigation could now be in Humana's future as it attempts to overturn some of the results of the ratings.

Humana has said it is taking steps to "mitigate" the anticipated impact to its 2026 revenue, although it has noted that the ratings decline is not expected to effect its financial outlook for the current year or 2025.

On Wednesday, the firm raised its forecast for 2024 individual Medicare Advantage annual membership growth by about 5% to approximately 265,000. It also lifted its full-year adjusted earnings per-share guidance to "at least" $16, up from its prior outlook of "approximately" $16.

In the quarter ended on Sept. 30, adjusted income per share of $4.16 came in well above consensus projections of $3.35, while revenue of $29.40 billion also beat expectations. In prepared remarks, Humana executives said the returns were driven by slightly higher than anticipated individual Medicare Advantage membership and outperformance at its CenterWell primary care centers.

"Proactive anticipation" of higher industry costs -- which have stemmed in part from more people choosing to undergo elective surgeries delayed by the COVID-19 pandemic -- underpinned results as well, the executives said.

Shares in Humana rose in early US trading.

This article first appeared in Investing.com

PRNews

DREO Named to TIME's List of the Best Inventions of 2024

CLIFTON, N.J., Oct. 31, 2024 /PRNewswire/ -- DREO, a leading innovator in smart home technology, today announced that its ChefMaker Combi ...

Cision | Thu, Oct 31 2024 04:00 AM AEDT

Read More
Stock Market

Raymond James cuts Crox on slower growth and margin pressure

Investing.com -- Raymond James downgraded Crocs (NASDAQ:CROX) to Market Perform from Outperform in a note Wednesday, citing concerns ...

Investing | Thu, Oct 31 2024 03:55 AM AEDT

Read More
PRNews

Think Eco, Move Green: Yutong Bus Completes Battery Mileage Challenge in Australia, Promotes Electric Transformation of Public Transport with Groundbreaking Technology Platform

MELBOURNE, Australia, Oct. 31, 2024 /PRNewswire/ -- Yutong Bus ("Yutong", SHA: 600066), a globally leading commercial vehicle manufacturer, has ...

Cision | Thu, Oct 31 2024 03:26 AM AEDT

Read More
PRNews

e& announces Q3 2024 earnings with consolidated revenue growth of 10% to AED 14.4 billion

e& completes acquisition of controlling stake in PPF Telecom and 100% acquisition of GlassHouse, expanding its footprint to 38 countries ABU ...

Cision | Thu, Oct 31 2024 03:13 AM AEDT

Read More
World News

City of Hope Honors AEG Presents' Jay Marciano at Spirit of Life Gala With Performances by Elton John, David Blaine and a Surprise Appearance by Celine Dion

October 30, 2024 /3BL/ - City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the ...

3BL | Thu, Oct 31 2024 03:05 AM AEDT

Read More